Clinical trials
Pancreatic Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Unknown status | 4 |
| Terminated | 3 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| Changi General Hospital | 2 |
| National Cancer Centre, Singapore | 2 |
| Revolution Medicines, Inc. | 2 |
| Al-Azhar University | 1 |
| Apollomics Inc. | 1 |
| Arbor Research Collaborative for Health | 1 |
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 35 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Colorectal Neoplasms | 5 |
| Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Stomach Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Cholangiocarcinoma | 3 |
| Colonic Neoplasms | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.